Paritaprevir/ritonavir/ombitasvir

DRUG2 trials

Sponsors

Kirby Institute, AbbVie

Conditions

Chronic Hepatitis CHepatitis C, Acute

Phase 3

Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P

CompletedNCT02634008

Kirby InstituteHepatitis C, Acute

Start: 2016-06-30End: 2021-04-30Updated: 2022-08-22

Unknown Phase

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C

CompletedNCT02725866

AbbVieChronic Hepatitis C

Start: 2016-04-05End: 2017-10-31Updated: 2019-03-15

Related Papers

Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study.

2023-07-276 citations